4.5 Article Proceedings Paper

The role of epigenetics in personalized medicine: challenges and opportunities

Journal

BMC MEDICAL GENOMICS
Volume 8, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1755-8794-8-S1-S5

Keywords

-

Funding

  1. Centre of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, KSA
  2. KACST Strategic Project [12-MED3078-03, 12-BIO2719-03, 12-BIO2267-03, 12-BIO3059-03, APR-34-13]

Ask authors/readers for more resources

Epigenetic alterations are considered to be very influential in both the normal and disease states of an organism. These alterations include methylation, acetylation, phosphorylation, and ubiquitylation of DNA and histone proteins (nucleosomes) as well as chromatin remodeling. Many diseases, such as cancers and neurodegenerative disorders, are often associated with epigenetic alterations. DNA methylation is one important modification that leads to disease. Standard therapies are given to patients; however, few patients respond to these drugs, because of various molecular alterations in their cells, which may be partially due to genetic heterogeneity and epigenetic alterations. To realize the promise of personalized medicine, both genetic and epigenetic diagnostic testing will be required. This review will discuss the advances that have been made as well as the challenges for the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available